CD19 - PDFSEARCH.IO - Document Search Engine

CD19
Results: 15

#	Item
1	Human CD19 B-Cells INSTRUCTION MANUAL ZBM0073.01 SHIPPING CONDITIONS Add to Reading List Source URL: www.zen-bio.com Language: English - Date: 2016-06-10 23:42:08
2	Product Datasheet Anti-CD19 antibody [EPR5906] ab134114 6 Images Add to Reading List Source URL: www.abcam.com Language: English
3	Additional File 1 - Supplementary Tables and Figure Table S1. Primary patient samples used for epigenetic analysis Sample type Age Sex Purification method* Purity Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English** Dynabeads Surface chemistry CD19
4	BLINCYTO™ (blinatumomab) Drug Class: Bispecific CD19-directed CD3 T-cell engager Amgen Inc. Add to Reading List Source URL: www.fda.gov Language: English Boxed warning Food and Drug Administration Hazards Pharmaceutical industry Medical error Patient safety Medicine Health Piperazines
5	Personalized Medicine Update Discussion of Recent Results on Protocol 793 titled: Pilot Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRζ and 4-1BB Signaling Domains in Patients wi Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 11:44:28 Biology Chimeric antigen receptor Co-stimulation Lymphocyte CD3 Plasma cell B cell CD28 CD20 Immune system T cells Anatomy
6	Update on A Phase I Study of CD19 CAR-Expressing T Cells in B-Cell NHL and CLL Carlos A. Ramos et al. Chimeric Antigen Receptors Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 12:36:19 Chimeric antigen receptor Co-stimulation CD28 B7 B cell CD19 T cells Anatomy Biology
7	OBA Protocol[removed]MSKCC IRB[removed]Phase I study of In Vitro expanded allogeneic Epstein-Barr Virus specific Cytotoxic T-Lymphocytes (EBV-CTLs) genetically targeted to B cell specific antigen CD 19 positive for In Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 12:39:20 Complement receptor 2 Complement system Epstein–Barr virus Chimeric antigen receptor CD19 Hematopoietic stem cell transplantation Leukemia Anti-CD19 immunotoxin Medicine Anatomy Biology
8	Session I Update on Current Approaches and Trials MDACC EXPERIENCE Laurence J.N. Cooper, M.D., Ph.D. MD Anderson Cancer Center Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:15:14 Stem cells Biotechnology Emerging technologies Hematopoietic stem cell transplantation Surgical oncology Complement receptor 2 Gene therapy CD19 B cell Biology Medicine T cells
9	ANTIGENS AND TOXICITY WITH DESIGNER T CELLS Under FDA/OBA: CEA, PSMA Foreign experience: G250, CEA, CD19, LeY Richard P Junghans, PhD, MD Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 13:16:23 Prostate cancer Tumor markers Carcinoembryonic antigen IgSF
10	Session I Update on Current Approaches and Trials MDACC EXPERIENCE Laurence J.N. Cooper, M.D., Ph.D. MD Anderson Cancer Center Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:31:11 Stem cells Biotechnology Emerging technologies Hematopoietic stem cell transplantation Surgical oncology Complement receptor 2 Gene therapy CD19 B cell Biology Medicine T cells

UPDATE